Clinical Trials · NCT04469855
Post-Marketing Surveillance (Special Use-results Surveillance) on Long-term Use With Ozempic®
- Phase
- N/A
- Recruitment status
- Completed
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 3,217
- Start date
- Jul 2020
- Locations
- 414 sites, Japan
- Primary endpoint
- Number of adverse events (AEs)